Expression of ADAM-9 mRNA and protein in human breast cancer
about
sameAs
Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migrationADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinomaADAM metalloproteases and EGFR signallingPlatelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.A disintegrin and metalloproteinase 9 is involved in ectodomain shedding of receptor-binding cancer antigen expressed on SiSo cells.Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration.A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer.Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer.The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?Implication of caspase-3 and granzyme B expression and activity in spleenocytes of ehrlich ascites carcinoma mice subjected to immunotherapymiR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1.Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells.Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera.ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade GliomasDown regulation of ADAM33 as a Predictive Biomarker of Aggressive Breast CancerInhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy.ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype.MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin.High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.Aberrant expression of disintegrin-metalloprotease proteins in the formation and progression of uterine cervical cancer.The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts.Overexpression of ADAM9 Promotes Colon Cancer Cells Invasion.Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells.High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer.Molecular profiling of ADAM12 and ADAM17 genes in human malignant melanoma.ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death.MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells.Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration.Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer.Sorting nexin 9 (SNX9) regulates levels of the transmembrane disintegrin and metalloproteinase (ADAM)-9 at the cell surface.Periodontal disease and gene-expression levels of metalloendopeptidases in human buccal mucosal epithelium.
P2860
Q24337698-CA1E3CC0-E521-442F-B1EE-CE88E7EFACE8Q24645750-EB2E66A4-E081-4BB1-8BD8-7CC1CC023082Q24803587-38A63D0A-3B71-4D0E-9C1A-3F19FDD041FBQ27333563-04C186DA-4EAD-4478-BCB4-6D42DC01BC4CQ31148772-C38FC59B-3192-479C-8CE7-F3A03B790825Q33346972-7CC69644-CE6C-4C4A-86EC-41F94A34CF80Q33737278-1A4DC64D-9A86-4688-A58D-AD9F23827772Q33794994-AAC9C18F-0189-46BD-ACFA-DC346EFE30B5Q34079881-264683BB-7866-4AD3-B0C2-D907A4898474Q34203948-101DB57F-8A8A-4A38-8A7D-B3EA8370CB80Q34296481-02DCEC30-8AD9-49EA-B888-606D93448363Q34334333-3CA3F1DA-86A9-40E8-B987-F4980271E4F3Q34769647-CB16A7B4-A69F-4850-9267-0738C976A024Q35206311-EB643943-F92E-40F4-A4DE-A18E7B115D65Q35602544-8C5F686D-E201-4963-8CCB-AEFF5FBA7736Q35921263-7EA4D2A3-46DA-47AF-A3D0-940DBB57398CQ36307894-C0F2A404-E85E-40CA-986A-744DA03D1A89Q36616716-D000C443-E311-4583-898B-685846EA5AA6Q36694831-0889A5AE-5230-4ACA-B32E-18BF3E54B74CQ37286187-2FBDA294-239B-44CE-8BC3-7D7129B11AACQ37704788-940FA668-439E-49E2-95A6-97528D88676BQ38478670-F0A39715-DD4E-4D00-B7E5-1C60D280A89AQ38694788-CABD7102-F789-4000-9D68-FAE1B7EB8275Q38995494-8569D455-746A-4B6C-8630-6887512159FEQ39093483-7BC8C309-5C5F-432B-8A46-FB5256E30464Q39281549-161E94F6-E376-499E-AF75-DB3C97BC309CQ39536282-09BB4868-C6C8-40CF-B023-E559CAEAD52DQ39623323-5888F908-2994-4402-8ACD-5AB528A48343Q39916438-64BE8EF3-B483-4D7D-B97F-155D6B0602D9Q40149856-DE3F9927-BEE1-43E8-B0FD-AB851C0D5A84Q40512485-C1EFCDA4-6303-44FD-A175-9AA79EAD52B3Q42149506-52A63FD2-012C-4C42-BD13-4EB79C2CFC96Q43650121-A8B73FDF-6BD9-47E6-B453-1A582C572BAFQ46238472-0D2A21BC-3D5F-4930-B98F-084048F95A5EQ47143534-ECEF99F4-7DE7-4519-A050-AEAE388C58F8Q47590431-09150C46-1555-4941-9696-B23ECAA0B2A9Q51558621-B227BB08-3076-4541-A2FA-FBAB74980080Q52603837-7B6BFF14-54BB-45B5-82E3-7EAB0B7B4C57Q54273943-149D7078-E61B-43A8-97E6-0A1B8E09A854
P2860
Expression of ADAM-9 mRNA and protein in human breast cancer
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expression of ADAM-9 mRNA and protein in human breast cancer
@ast
Expression of ADAM-9 mRNA and protein in human breast cancer
@en
Expression of ADAM-9 mRNA and protein in human breast cancer
@nl
type
label
Expression of ADAM-9 mRNA and protein in human breast cancer
@ast
Expression of ADAM-9 mRNA and protein in human breast cancer
@en
Expression of ADAM-9 mRNA and protein in human breast cancer
@nl
prefLabel
Expression of ADAM-9 mRNA and protein in human breast cancer
@ast
Expression of ADAM-9 mRNA and protein in human breast cancer
@en
Expression of ADAM-9 mRNA and protein in human breast cancer
@nl
P2093
P3181
P356
P1476
Expression of ADAM-9 mRNA and protein in human breast cancer
@en
P2093
Arnold D K Hill
Caroline O'Shea
Enda McDermott
Michael J Duffy
Niall O'Higgins
Norman McKie
Yvonne Buggy
P304
P3181
P356
10.1002/IJC.11161
P407
P577
2003-07-20T00:00:00Z